|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.23 AUD | -1.77% |
|
+3.87% | +0.95% |
| 03-13 | ASX Biggest Losers | MT |
| 01-14 | Evans & Partners Starts ALS at Positive with AU$25.80 Price Target | MT |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.62 | 9.04 | 9.46 | 8.32 | 7.79 | |||||
Return on Total Capital | 7.77 | 10.93 | 11.24 | 9.9 | 9.36 | |||||
Return On Equity % | 15.9 | 17.47 | 22.03 | 1.16 | 20.79 | |||||
Return on Common Equity | 15.91 | 17.49 | 22.11 | 1.01 | 20.8 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 29.38 | 30.14 | 33.03 | 31.63 | 29.62 | |||||
SG&A Margin | 5.6 | 5.29 | 5.84 | 5.57 | 5.72 | |||||
EBITDA Margin % | 21.02 | 22.41 | 24.81 | 23.29 | 20.53 | |||||
EBITA Margin % | 16.74 | 18.71 | 20.5 | 19.6 | 16.83 | |||||
EBIT Margin % | 16.25 | 18.26 | 20.5 | 18.99 | 16.12 | |||||
Income From Continuing Operations Margin % | 9.88 | 9.12 | 12.12 | 0.61 | 8.63 | |||||
Net Income Margin % | 9.8 | 9.03 | 12.78 | 0.52 | 8.54 | |||||
Net Avail. For Common Margin % | 9.8 | 9.03 | 12.07 | 0.52 | 8.54 | |||||
Normalized Net Income Margin | 8.94 | 10.45 | 11.58 | 10.38 | 8.48 | |||||
Levered Free Cash Flow Margin | 17.21 | 9.81 | 10.61 | 8.59 | 7.64 | |||||
Unlevered Free Cash Flow Margin | 18.71 | 11.01 | 12 | 10.3 | 9.57 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.65 | 0.79 | 0.74 | 0.7 | 0.77 | |||||
Fixed Assets Turnover | 2.57 | 3.18 | 3.03 | 2.68 | 2.82 | |||||
Receivables Turnover (Average Receivables) | 5.93 | 6.97 | 6.87 | 6.46 | 6.78 | |||||
Inventory Turnover (Average Inventory) | 17.36 | 21.73 | 17.7 | 16.04 | 17.69 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.62 | 0.87 | 1.23 | 1.21 | 1.53 | |||||
Quick Ratio | 1.34 | 0.69 | 0.97 | 0.99 | 1.16 | |||||
Operating Cash Flow to Current Liabilities | 0.71 | 0.39 | 0.72 | 0.41 | 0.55 | |||||
Days Sales Outstanding (Average Receivables) | 61.51 | 52.34 | 53.14 | 56.65 | 53.84 | |||||
Days Outstanding Inventory (Average Inventory) | 21.02 | 16.8 | 20.62 | 22.81 | 20.63 | |||||
Average Days Payable Outstanding | 20.26 | 17.11 | 20.34 | 24.12 | 24.37 | |||||
Cash Conversion Cycle (Average Days) | 62.28 | 52.03 | 53.43 | 55.34 | 50.09 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 89.62 | 109.45 | 105.08 | 156.42 | 161.74 | |||||
Total Debt / Total Capital | 47.26 | 52.26 | 51.24 | 61 | 61.79 | |||||
LT Debt/Equity | 85.71 | 79.18 | 92.05 | 129.84 | 149.08 | |||||
Long-Term Debt / Total Capital | 45.2 | 37.8 | 44.89 | 50.63 | 56.96 | |||||
Total Liabilities / Total Assets | 56.41 | 60.25 | 58.61 | 67.62 | 68.14 | |||||
EBIT / Interest Expense | 6.78 | 9.53 | 9.21 | 6.92 | 5.22 | |||||
EBITDA / Interest Expense | 9.83 | 12.87 | 12.22 | 9.41 | 7.65 | |||||
(EBITDA - Capex) / Interest Expense | 7.91 | 9.92 | 9.34 | 7.17 | 5.87 | |||||
Total Debt / EBITDA | 2.33 | 2.38 | 2.34 | 2.94 | 2.95 | |||||
Net Debt / EBITDA | 1.93 | 2.14 | 2.05 | 2.47 | 2.57 | |||||
Total Debt / (EBITDA - Capex) | 2.9 | 3.09 | 3.06 | 3.86 | 3.84 | |||||
Net Debt / (EBITDA - Capex) | 2.39 | 2.78 | 2.68 | 3.24 | 3.35 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -4.99 | 19.71 | 16.77 | 8 | 21.85 | |||||
Gross Profit, 1 Yr. Growth % | -0.37 | 22.83 | 21.36 | 3.43 | 14.12 | |||||
EBITDA, 1 Yr. Growth % | -2.55 | 27.66 | 21.1 | 1.4 | 7.41 | |||||
EBITA, 1 Yr. Growth % | -2.61 | 33.9 | 23.21 | 1.11 | 4.62 | |||||
EBIT, 1 Yr. Growth % | -2.98 | 34.56 | 23.21 | 0.06 | 3.42 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 123.21 | 12.33 | 44.21 | -94.57 | 1.63K | |||||
Net Income, 1 Yr. Growth % | 35.05 | 12.32 | 52.86 | -95.57 | 1.89K | |||||
Normalized Net Income, 1 Yr. Growth % | -0.9 | 42.38 | 21.71 | -3.24 | -0.36 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 126.45 | 12.17 | 44.67 | -95.32 | 1.92K | |||||
Accounts Receivable, 1 Yr. Growth % | -8.98 | 13.75 | 6.25 | 22.87 | 10.62 | |||||
Inventory, 1 Yr. Growth % | -18.38 | 10.56 | 42.28 | 7.11 | 19.91 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -11.84 | 9.84 | 17.18 | 26.18 | 7.73 | |||||
Total Assets, 1 Yr. Growth % | -15.48 | 14.61 | 17.08 | 10.99 | 9.9 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.57 | -19.07 | -37.08 | 595.11 | 23.97 | |||||
Common Equity, 1 Yr. Growth % | -2.83 | 5.8 | 22.03 | -13.43 | 8.15 | |||||
Cash From Operations, 1 Yr. Growth % | 4.25 | 7.9 | 53.38 | -20.41 | 17 | |||||
Capital Expenditures, 1 Yr. Growth % | -33.03 | 54.62 | 22.88 | 3.83 | 8.77 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 153.59 | -33 | 23.55 | -12.64 | 8.38 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 124.58 | -30.74 | 23.91 | -7.31 | 13.17 | |||||
Dividend Per Share, 1 Yr. Growth % | 31.25 | 41.99 | 21.04 | -1.26 | -1.53 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.86 | 6.65 | 13.75 | 12.3 | 14.72 | |||||
Gross Profit, 2 Yr. CAGR % | 4.91 | 10.61 | 20.62 | 12.04 | 8.64 | |||||
EBITDA, 2 Yr. CAGR % | 2.62 | 11.52 | 23.58 | 10.81 | 4.36 | |||||
EBITA, 2 Yr. CAGR % | 2.64 | 14.18 | 25.91 | 12.79 | 2.85 | |||||
EBIT, 2 Yr. CAGR % | 1.7 | 14.24 | 27.77 | 11.03 | 1.73 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 1.83 | 56.97 | 27.08 | -72.02 | -3.2 | |||||
Net Income, 2 Yr. CAGR % | 6.35 | 22.09 | 31.03 | -73.98 | -6.2 | |||||
Normalized Net Income, 2 Yr. CAGR % | 1.33 | 17.72 | 30.63 | 8.52 | -1.81 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 2.14 | 57.98 | 27.19 | -73.98 | -3.71 | |||||
Accounts Receivable, 2 Yr. CAGR % | 1.61 | 1.75 | 9.93 | 14.26 | 16.58 | |||||
Inventory, 2 Yr. CAGR % | -5.29 | -5 | 25.42 | 23.45 | 13.33 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 20.93 | -2.35 | 13.45 | 21.59 | 16.59 | |||||
Total Assets, 2 Yr. CAGR % | 6.62 | -1.49 | 15.84 | 14 | 10.45 | |||||
Tangible Book Value, 2 Yr. CAGR % | 56.96 | 11.12 | -28.64 | 109.13 | 193.55 | |||||
Common Equity, 2 Yr. CAGR % | -0.21 | 0.9 | 13.63 | 2.78 | -3.24 | |||||
Cash From Operations, 2 Yr. CAGR % | 11.09 | 5.23 | 28.65 | 10.49 | -3.51 | |||||
Capital Expenditures, 2 Yr. CAGR % | -13.7 | -0.91 | 37.84 | 12.95 | 6.27 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 41.09 | 31.53 | -11.48 | 3.89 | -2.69 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 37.85 | 25.76 | -9.64 | 7.17 | 2.42 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.32 | 36.52 | 31.1 | 9.32 | -1.4 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.78 | 8.19 | 7.13 | 11.8 | 15.4 | |||||
Gross Profit, 3 Yr. CAGR % | 9.22 | 10.56 | 13.17 | 14.59 | 12.72 | |||||
EBITDA, 3 Yr. CAGR % | 8.78 | 10.36 | 14.16 | 15.7 | 9.67 | |||||
EBITA, 3 Yr. CAGR % | 10.3 | 12.14 | 15.57 | 17.85 | 10 | |||||
EBIT, 3 Yr. CAGR % | 9.66 | 11.63 | 16.55 | 17.77 | 8.44 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 37.21 | 4.61 | 52.44 | -55.58 | 10.56 | |||||
Net Income, 3 Yr. CAGR % | 49.36 | 7.67 | 31.59 | -57.63 | 10.38 | |||||
Normalized Net Income, 3 Yr. CAGR % | 9.79 | 12.82 | 18.42 | 18.19 | 5.48 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 39.61 | 4.77 | 53.25 | -57.7 | 10.29 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.01 | 5.51 | 3.23 | 14.09 | 13.03 | |||||
Inventory, 3 Yr. CAGR % | -5.29 | -0.28 | 8.69 | 18.99 | 22.25 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 17.03 | 16.51 | 3.77 | 17.54 | 16.78 | |||||
Total Assets, 3 Yr. CAGR % | 6.37 | 9.29 | 4.35 | 14.2 | 12.62 | |||||
Tangible Book Value, 3 Yr. CAGR % | -19.52 | 39.7 | -8.07 | 52.4 | 75.68 | |||||
Common Equity, 3 Yr. CAGR % | -1.25 | 1.43 | 7.51 | 3.78 | 4.54 | |||||
Cash From Operations, 3 Yr. CAGR % | 13.27 | 9.44 | 19.31 | 9.62 | 12.61 | |||||
Capital Expenditures, 3 Yr. CAGR % | 3.38 | 2.97 | 6.46 | 25.42 | 11.54 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 17.81 | 10.74 | 26.48 | -11.87 | 5.37 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 17.81 | 10.2 | 23.08 | -8.87 | 9.13 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.76 | 13.39 | 31.15 | 19.28 | 5.58 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.29 | 10.82 | 9.51 | 8.14 | 10.1 | |||||
Gross Profit, 5 Yr. CAGR % | 7.87 | 12.88 | 13.64 | 10.61 | 11.33 | |||||
EBITDA, 5 Yr. CAGR % | 7.7 | 13.59 | 14.47 | 10.27 | 10.14 | |||||
EBITA, 5 Yr. CAGR % | 9.62 | 16.4 | 16.29 | 11.51 | 10.77 | |||||
EBIT, 5 Yr. CAGR % | 10.86 | 16.02 | 16.57 | 11.05 | 10.38 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -5.32 | 13.18 | 32.6 | -38.31 | 27.12 | |||||
Net Income, 5 Yr. CAGR % | -6.44 | 18.48 | 41.24 | -38.99 | 14.92 | |||||
Normalized Net Income, 5 Yr. CAGR % | 12.86 | 17.69 | 17.27 | 10.74 | 9.87 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -6.61 | 14.19 | 34.03 | -40.02 | 27.26 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.16 | 7.08 | 6.34 | 8.92 | 8.38 | |||||
Inventory, 5 Yr. CAGR % | -4 | 1.16 | 5.97 | 8.61 | 10.52 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.99 | 11.88 | 15.23 | 18.52 | 8.72 | |||||
Total Assets, 5 Yr. CAGR % | 2.92 | 5.76 | 10.1 | 11.15 | 6.75 | |||||
Tangible Book Value, 5 Yr. CAGR % | -23.24 | -17.36 | -18.35 | 64.16 | 46.26 | |||||
Common Equity, 5 Yr. CAGR % | -1.91 | -0.96 | 4.25 | 1.97 | 3.07 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.75 | 10.35 | 18.81 | 9.86 | 9.6 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.93 | 15.16 | 14.76 | 6.85 | 6.38 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 17.98 | 35.17 | 5.46 | 6.77 | 13.89 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.41 | 29.84 | 6.3 | 7.9 | 14.36 | |||||
Dividend Per Share, 5 Yr. CAGR % | 11.34 | 19.43 | 18.49 | 11.74 | 17.01 |
- Stock Market
- Equities
- ALQ Stock
- Financials ALS Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















